Drug recall · April 3, 2024
Divalproex Sodium Extended-release Tablets recall
Why: Failed dissolution specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10
- Lots / codes
Lot # AR210704, exp. date 04/2024 AR210706, exp. date 04/2024 AR210707, exp. date 04/2024 AR210708, exp. date 04/2024 AR210709, exp. date 04/2024
- Quantity
- 21,452/100 count bottles
- Company
- Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
- Distribution
- Product was distributed nationwide.
- Initiated
- December 26, 2023 · Voluntary: Firm initiated
- Classified
- March 27, 2024
- Reported
- April 3, 2024
- Ended
- August 16, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valproate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.